Clinical Trial Update: Anlotinib or Penpulimab in Combination With RAI for DTC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring anlotinib or penpulimab in combination with radioactive iodine for differentiated thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer
• Thyroid Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Penpulimab

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Thyroid Cancer | Phase 2 | Status: UNKNOWN